Sagimet Biosciences Inc
NASDAQ:SGMT
Sagimet Biosciences Inc
NASDAQ:SGMT
Price:
5.64
USD
3.49%
Market Cap:
$181.6m
Balance Sheet
Balance Sheet Decomposition
Sagimet Biosciences Inc
Sagimet Biosciences Inc
Balance Sheet Decomposition is not available for
Sagimet Biosciences Inc
Sagimet Biosciences Inc
Balance Sheet
Sagimet Biosciences Inc
Sagimet Biosciences Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
10
|
69
|
57
|
0
|
75
|
76
|
|
| Cash Equivalents |
10
|
69
|
57
|
0
|
75
|
76
|
|
| Short-Term Investments |
0
|
0
|
0
|
32
|
20
|
75
|
|
| Other Current Assets |
1
|
0
|
2
|
0
|
2
|
2
|
|
| Total Current Assets |
11
|
69
|
59
|
33
|
97
|
153
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
7
|
|
| Total Assets |
11
N/A
|
69
+518%
|
59
-14%
|
33
-44%
|
97
+193%
|
160
+66%
|
|
| Liabilities | |||||||
| Accounts Payable |
1
|
1
|
1
|
1
|
0
|
1
|
|
| Accrued Liabilities |
1
|
1
|
1
|
4
|
5
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
2
|
2
|
2
|
5
|
6
|
4
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
2
-14%
|
3
+35%
|
5
+101%
|
6
+5%
|
4
-21%
|
|
| Equity | |||||||
| Common Stock |
134
|
203
|
215
|
215
|
0
|
0
|
|
| Retained Earnings |
156
|
167
|
191
|
222
|
250
|
295
|
|
| Additional Paid In Capital |
30
|
31
|
33
|
35
|
341
|
451
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
9
N/A
|
67
+656%
|
56
-16%
|
28
-51%
|
91
+229%
|
156
+71%
|
|
| Total Liabilities & Equity |
11
N/A
|
69
+518%
|
59
-14%
|
33
-44%
|
97
+193%
|
160
+66%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
22
|
22
|
22
|
22
|
23
|
32
|
|
| Preferred Shares Outstanding |
759
|
1 289
|
1 374
|
1 374
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
